Post categorized under: Cannabis
With the Cannabis industry increasingly competitive for labs, growers and processors, new innovation and improved practices can be the difference in delivering ROI and outlasting competitors. PathogenDx delivers a unique Microarray technology that dramatically reduces testing turnaround time, adds flexibility to how and what can be tested for, and increases efficiencies for a cleaner Cannabis future. Here are the issues Cannabis faces now, with insights to help us all compete and win.
- Minnesota Legalizes Adult-Use Recreational Cannabis
The new law modifies Minnesota’s list of controlled substances to exclude “industrial hemp” products that contain no more than 0.3% of any form of THC. That change brought Minnesota law in line with federal law. However, the law also allows Minnesota businesses to sell edible and drinkable products containing no more than five milligrams of THC per serving and no more than 50 milligrams of THC per package to people ages 21 and older.
- New York Regulators Approve Adult-Use Cannabis Testing Regulations
The approved interim regulations for New York’s Cannabis testing labs will ensure adult-use Cannabis products are not contaminated with pesticides, heavy metals or other adulterations. The rules will allow medical Cannabis testing labs to expand their operations to serve the adult-use market as well.
- South Dakota Adds New Standards for Testing Medical Cannabis
The effect of the rules will be to add regulations on testing of medical cannabis, including creation of batches and collection of samples. Under the rules, Cannabis testing labs must also update the inventory tracking system daily with all samples collected and the results of all tests performed.
- Why Utah Isn’t Testing Medical Marijuana
For over a year, Utah has not been pathogen testing medical marijuana for the typically tested for pathogenic bacteria. Last April, the Utah Department of Agriculture and Food suspended the requirement for pathogen-specific testing.
The short answer: due to an equipment shortage, the state said it suspended Cannabis lab testing for E.coli, salmonella and several kinds of molds that cause illness, especially among the immunocompromised.
- California to Standardize Cannabis Lab Testing to Stop ‘Laboratory Shopping’
The California Department of Cannabis Control announced plans to standardize Cannabis lab testing methods amid concerns about exaggerated potency and “lab shopping” by businesses. Somewhat troubling, the department reports marijuana businesses are choosing labs that report higher THC levels than what is actually contained in the Cannabis. At PathogenDx, we stress that accurate and honest Cannabis pathogen testing is good for the future of the industry.
- Connecticut Lawmakers Approve New Medical Cannabis Testing Regulations
A legislative committee in Connecticut signed off on new medical Cannabis testing regulations that were proposed by regulators earlier this year. The new rules would set new allowable levels Total Yeast and Mold at a limit of 100,000 colony forming units per gram and would not allow any detectable levels of Aspergillus.
- More Stringent Cannabis Lab Testing Needed in the Industry
With the increasing demand for legal Cannabis and heightened participation of various states, the need for comprehensive and rigorous Cannabis bacteria testing solutions has now become vital. Considering a lot of individuals use Cannabis products for medical purposes, they should have to worry about falling ill from consuming pathogenic bacteria infested Cannabis products. While there could be federal criteria for Cannabis pathogen testing prerequisite, that can’t happen just yet as cannabis isn’t legal at the federal level.
- State Regulations Key to Success in NM Cannabis Economy
Recreational cannabis has been legalized for sale since April 1. So far, the industry has realized more than $40 million in revenue, and has even passed the Cannabis Regulation Act. The legislature not only looks to standardize rules of sale and Cannabis testing regulation across the state, but to assure New Mexico state regulations Cannabis testing are stringent from the get-go.
- At least 28 Mississippi cities have opted out of medical marijuana, but the state is not keeping track
28 cities and a dozen counties completely opted out of Mississippi’s long-awaited medical marijuana program by the May 3 deadline, but the state’s health department is creating legal confusion by not keeping an official list of municipalities restricting Cannabis businesses. The Mississippi Cannabis Trade Association, a business and advocate group, has put together the most complete list showing that areas have opted out of the program.
- Cannabis Testing Regulations Are Complex, Differing From State to State
Unlike food and other products there is no federal standard, and Cannabis lab testing is done by private entities. One is Belcosta Labs in southern California, which is looking to operate in New Jersey. Like New Jersey, California Cannabis regulations require products be tested for potency, for pesticides and for the presence of various microbials and mycotoxins, those that come from a fungus.